Apogee Therapeutics, Inc. (APGE)
NASDAQ·Healthcare·Biotechnology
$135.07
—
Mkt Cap $8.36B
Analyst Ratings
Buy
7
Hold
12
Sell
0
Price Target (22 analysts)
$122.75
Range $81.00 – $140.00
Implied Upside
-9.1%
Consensus $122.75 vs current $135.07
NASDAQ·Healthcare·Biotechnology
$135.07
—
Mkt Cap $8.36B
Buy
7
Hold
12
Sell
0
Price Target (22 analysts)
$122.75
Range $81.00 – $140.00
-9.1%
Consensus $122.75 vs current $135.07